Anti-Fungal Prophylaxis Using Intermediate Dose Ambisome Is Associated with Delayed Methotrexate Clearance in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Anti-Fungal Prophylaxis Using Intermediate Dose Ambisome Is Associated with Delayed Methotrexate Clearance in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationConference abstracts
Source: The Aspergillus Website - updates - Category: Respiratory Medicine Authors: MeganB Source Type: news
More News: Aspergillus | Methotrexate | Pediatrics | Respiratory Medicine | Stem Cell Therapy | Stem Cells | Transplants | Websites